Sahaj Regenerative Cell Therapeutics

Sahaj Regenerative Cell Therapeutics is an Indian biotechnology and healthcare company specializing in advanced cell research and regenerative medicine. The company is known for developing Sahaj Therapy, a patented, minimally invasive autologous grafting procedure that utilizes adipose tissue-derived stromal vascular fraction (SVF) to treat joint pain, knee osteoarthritis, and early-stage avascular necrosis (AVN). The technology isolates SVF using direct ultrasonic cavitation without the use of enzymes, chemicals, or animal products, allowing the entire procedure to be completed in a single surgical sitting. Sahaj Regenerative Cell Therapeutics operates clinics across India, providing a biological solution for joint preservation and self-healing.